new_logo_anew_logo_anew_logo_anew_logo_a
  • Company
    • Company
    • Our Mission
    • Leadership
    • Pipeline
  • Technology
    • Quantum Engine™
    • GTailor™
    • Quantum Nufect™
    • Quantum pBac™
    • iCellar™
    • qCART™
    • Protein / Target Hunter
  • Clinical trial
  • Partnership
  • Media
    • Events & Presentations
    • Publications
  • Careers
  • Contact Us
  • en_USEnglish
    • zh_TW繁體中文
✕
Quantum pBac™ platform technology to be patented in New Zealand
2023-08-21
Our Founder/CEO/CSO, Sareina Wu, and BD Director, Ting-Wan, will present as an invited expert speaker at 7th Annual CAR-TCR Summit Europein London, UK (February27-29, 2024)
2024-01-29
Our Founder/CEO/CSO, Sareina Wu, and BD Director, Ting-Wan, will present as an invited expert speaker at 7th Annual CAR-TCR Summit Europein London, UK (February27-29, 2024)
2024-01-29
Quantum pBac™ platform technology to be patented in New Zealand
2023-08-21

GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials

For more information: https://www.prnewswire.com/news-releases/genomefrontier-selects-biocina-to-manufacture-minicircle-and-plasmid-dna-for-their-car-t-cell-therapy-product-301958160.html

Share
0

留言 Cancel reply

Your email address will not be published. Required fields are marked *

Company

  • Our Mission
  • Leadership
  • Pipeline

Our Technology

  • GTailor
  • Quantum Nufect
  • Quantum pBac
  • iCellar
  • qCART
  • Protein / Target Hunter

Clinical Trial


Media

  • Events & Presentation
  • Publication

Partnership

Careers

Contact Us

© 2025 GenomeFrontier Therapeutics TW Co., Ltd. All Rights Reserved.